We found P21 and P27, mediated by EGFR-AKT signaling, promoted cell cycle progression in tumor occurrence and development in seminal vesicles of TRAMP mice while WT P53 function was lost, which potentially expanded and deepened the understanding of the preclinical model TRAMP of human prostate cancer. The gene discussed is AKT1; the disease is neoplasm.